A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates

MLA

Susan Pereira Ribeiro, et al. “A Promiscuous T Cell Epitope-Based HIV Vaccine Providing Redundant Population Coverage of the HLA Class II Elicits Broad, Polyfunctional T Cell Responses in Nonhuman Primates.” Vaccine, vol. 40, Jan. 2022, pp. 239–46. EBSCOhost, https://doi.org/10.1016/j.vaccine.2021.11.076.

APA

Susan Pereira Ribeiro, Vania Gomes De Moura Mattaraia, Rafael Ribeiro Almeida, Elizabeth Juliana Ghiuro Valentine, Natiely Silva Sales, Luís Carlos S. Ferreira, Luiz Carlos Sa-Rocha, Lucas Cauê Jacintho, Vinicius Canato Santana, John Sidney, Alessandro Sette, Daniela Santoro Rosa, Jorge Kalil, & Edecio Cunha-Neto. (2022). A promiscuous T cell epitope-based HIV vaccine providing redundant population coverage of the HLA class II elicits broad, polyfunctional T cell responses in nonhuman primates. Vaccine, 40, 239–246. https://doi.org/10.1016/j.vaccine.2021.11.076

Chicago

Susan Pereira Ribeiro, Vania Gomes De Moura Mattaraia, Rafael Ribeiro Almeida, Elizabeth Juliana Ghiuro Valentine, Natiely Silva Sales, Luís Carlos S. Ferreira, Luiz Carlos Sa-Rocha, et al. 2022. “A Promiscuous T Cell Epitope-Based HIV Vaccine Providing Redundant Population Coverage of the HLA Class II Elicits Broad, Polyfunctional T Cell Responses in Nonhuman Primates.” Vaccine 40 (January): 239–46. doi:10.1016/j.vaccine.2021.11.076.